Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of recombinant acellular pertussis-containing vaccines in healthy adolescents
TCTR20181031001Phase 3Completed
- Sponsor
- Chulalongkorn University
- Start
- May 2019
- Countries
- 1
01
Overview
Phase 3 trial in pertussis, sponsored by Chulalongkorn University. Started May 2019; status: completed.
02
Conditions
pertussis
Beyond the preview
Go deeper on TCTR20181031001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20181031001.